Skip to main content
Mantapex
When will Intellia Therapeutics submit a BLA for Lonvo-z?
Lonvoguran Ziclumeran (lonvo-z) - BLAScience
Kalshi Active 6 markets·77¢ When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?·$0 Total Volume·-- Liquidity·-- OI
2mo·Sep 8, 2026

Track your prediction positions

Connect your Kalshi account to track your contracts, P&L, and settlements.

Wide spread
No chart data available

Markets

6
Inc. Lonvoguran Ziclumeran (lonvo-z) FDA
$0 vol
77% ▲0.0%
Inc. Lonvoguran Ziclumeran (lonvo-z) FDA
$0 vol
70% ▲0.0%
Inc. Lonvoguran Ziclumeran (lonvo-z) FDA
$0 vol
67% ▲0.0%
Inc. Lonvoguran Ziclumeran (lonvo-z) FDA
$0 vol
64% ▲0.0%
Inc. Lonvoguran Ziclumeran (lonvo-z) FDA
$0 vol
55% ▲0.0%
Inc. Lonvoguran Ziclumeran (lonvo-z) FDA
No order book data available

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes.

Series

KXNEWDRUGAPPNTLA
View Full Series

Track Your Bets on Kalshi — and Everything Else

Create a free portfolio starting with your Kalshi positions, P&L & live odds. Then add crypto wallets, exchanges, DeFi & more — all in one place.

Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% free· Read-only· Encrypted